Information2022
-
Dec. 27, 2022
IR(Change of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business
-
Dec. 20, 2022
IRNotice Regarding Acquisition of Odin Medical Ltd. (to make it a subsidiary) in the UK
-
Dec. 16, 2022
IRNotice Regarding Termination of Sponsored American Depositary Receipt (ADR) Program
-
Dec. 09, 2022
IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System
-
Dec. 02, 2022
IRNotice Regarding Status of Share Repurchase
-
Nov. 21, 2022
IR(Updated) Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
-
Nov. 21, 2022
IR(Updated) Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System
- Nov. 11, 2022 IRSecond Quarter Financial Results
-
Nov. 11, 2022
IRNotice Concerning Recording Gain on Transfer of Shares and Revision to Financial Forecasts
-
Nov. 11, 2022
IRNotice Regarding Share Repurchase and Cancellation of Treasury Shares
-
Nov. 11, 2022
IRNotice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System
-
Oct. 21, 2022
IRNotice Concerning Changes of Representative Executive Officer and Management Team
- Sep. 30, 2022 IRPublished Integrated Report 2022
- Sep. 28, 2022 CorporateOlympus globalizes further and invests 32 million euros in new medical equipment repair facilities in Coimbra, Portugal
-
Aug. 29, 2022
IRNotice Concerning Transfer of Shares of Specified Subsidiary engaged in Scientific Solutions Business
-
Aug. 23, 2022
IRCompany Response to Today’s Media Reports
- Aug. 09, 2022 IRFirst Quarter Financial Results
- Jul. 25, 2022 CorporateThe Sustainability page annual updated
-
Jul. 22, 2022
IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
-
Jun. 24, 2022
IRNotice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
-
Jun. 17, 2022
IROverview of Evaluation Results on the Effectiveness of the Board of Directors of Olympus
- Jun. 08, 2022 CorporateOlympus Provi™ CM20 Wins Highest Honor in World-Renowned Design Competition
- May. 11, 2022 IRFinancial Results
-
May. 11, 2022
IRNotice Regarding Cancellation of Treasury Shares
- Apr. 19, 2022 CorporateOlympus Donates to the International Federation of Red Cross and Red Crescent Societies to Support Victims of the Crisis in Ukraine
-
Apr. 06, 2022
IRNotice Concerning Capital Increase in Subsidiary (Change to Specified Subsidiary)
-
Apr. 01, 2022
IR(Progress of Disclosure Matters) Notice Concerning Complete of Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)
-
Mar. 30, 2022
IRNotice Regarding Transfer of Non-current Asset and Recognition of Other Income
- Mar. 28, 2022 CorporateOlympus suspends its Scientific Solutions business in Russia
- Mar. 03, 2022 CorporateOlympus will join the global relief effort to help the people of Ukraine
- Feb. 25, 2022 CorporateOlympus Selected as a Supplier Engagement Leader 2021, the Highest Rating in the CDP Supplier Engagement Rating
- Feb. 24, 2022 IROlympus Wins Award for Excellence at the Nikkei Integrated Report Awards 2021
-
Feb. 22, 2022
IRNotice Regarding the Status and Completion of Stock Repurchase
- Feb. 04, 2022 IRThird Quarter Financial Results
-
Feb. 04, 2022
IRNotification for the Candidate for the Board of Directors
-
Feb. 02, 2022
IRNotice Regarding the Status of Stock Repurchase
-
Jan. 24, 2022
IRNotice Concerning Judgement of the Lawsuit against Consolidated Subsidiary and Launch of Appeal
-
Jan. 05, 2022
IRNotice Regarding the Status of Stock Repurchase